Prospective study of tricuspid valve regurgitation associated with permanent leads in patients undergoing cardiac rhythm device implantation: Background, rationale, and design

Global Cardiology Science and Practice

Volumn 2015, Issue 3, 2015, Pages

  Dokainish, Hisham ^a   Elbarasi, Esam ^a   Masiero, Simona ^b   Van De Heyning, Caroline ^c   Brambatti, Michela ^b   Ghazal, Sami ^a   AL Maashani, Said ^a   Capucci, Alessandro ^b   Buikema, Lisanne ^a   Leong, Darryl ^a   Shivalkar, Bharati ^c   Saenen, Johan ^c   Miljoen, Hielko ^c   Morillo, Carlos ^a   Divarakarmenon, Syam ^a   Amit, Guy ^a   Ribas, Sebastian ^a   Brautigam, Aaron ^a   Baiocco, Erika ^b   Maolo, Alessandro ^b   Romandini, Andrea ^b   Maffei, Simone ^b   Stuart, Connolly ^a   Jeff, Healey ^a   more..

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR JUNCTION ARRHYTHMIA; BIVENTRICULAR ASSIST DEVICE; CARDIAC RESYNCHRONIZATION THERAPY; COLOR ULTRASOUND FLOWMETRY; DEFIBRILLATION; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MEDICAL DEVICE COMPLICATION; METHODOLOGY; MULTICENTER STUDY; PACEMAKER IMPLANTATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; TREATMENT INDICATION; TRICUSPID VALVE REGURGITATION; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 85018430849     PISSN: None     EISSN: 23057823     Source Type: Journal    
DOI: 10.5339/gcsp.2015.41     Document Type: Article

References (36)

1. Mond HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverterBdefibrillators: calendar year 2009BBa World Society of Arrhythmia's project. Pacing Clin Electrophysiol 2011;34:1013-27.
2. Kurtz SM, Ochoa J A, Lau E, Shkolnikov Y, Pavri BB, Frisch D, Greenspon AJ. Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States:1993-2006. Pacing Clin Electrophysiol 2010;33:705-11.
3. Kremers MS, Hammill SC, Berul CI, Koutras C, Curtis JS, Wang Y, Beachy J, Blum Meisnere L, Conyers del M, Reynolds MR, Heidenreich PA, AlBKhatib SM, Pina IL, Blake K, Norine Walsh M, Wilkoff BL, Shalaby A, Masoudi FA, Rumsfeld J. The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011. Heart Rhythm 2013;10:e59-65.
4. Paniagua D, Aldrich HR, Lieberman EH, Lamas GA, Agatston AS. Increased prevalence of significant tricuspid regurgitation in patients with transvenous pacemakers leads. Am J Cardiol 1991;82:1130-2, A9.
5. De Cock CC, Vinkers N, van Campe LC, Verhorst PM, Visser CA. LongBterm outcome of patients with multiple (3) noninfected transvenous leads: a clinical and echographic study. Pacing Clin Electrophysiolog 2000;23:423-426.
6. Klutstein M, Balkin J, Butnaru A, Ilan M, Lahad A, Rosenmann D. Tricuspid incompetence following permanent pacemaker implantation. Pacing Clin Electrophysiol 2009;32 Suppl 1:S135B 137.
7. Webster G, Margossian R, Alexander ME, Cecchin F, Triedman JK, Walsh EP, Berul CI. Impact of transvenous ventricular pacing leads on tricuspid regurgitation in pediatric and congenital heart disease patients. J Interv Card Electrophysiology 2008;21:65-68.
8. Kim JB, Spevack DM, Tunick PA, Bullinga JR, Kronzon I, Chinitz LA, Reynolds HR. The effect of transvenous pacemaker and implantable cardioverter defibrillator lead placement on tricuspid valve function: an observational study. J Am Soc Echocardiogr. 2008;21:284-7.
9. Sadreddini M, Haroun M, Buikema L, Morillo C, Ribas S, Divarakaramenon S, Connolly SJ, Nieuwlaat R, Lonn EM, HealeyJS, Dokainish H. Tricuspid valve regurgitation induced by temporary or permanent endocardial lead insertion, and the impact of cardiac resynchronization therapy. Open Cardiovasc Med Journal, 2014; 8:83-87.
10. AlBBawardy R, Krishnaswamy A, Rajeswaran J, Bhargava M, Wazni O, Wilkoff B, Tuzcu EM, Martin D, Thomas J, Blackstone E, Kapadia S. Tricuspid regurgitation and implantable devices. Pacing Clin Electrophysiol 2015;38:259-66.
11. Kucukarslan N, Kirilmaz A, Ulusoy E, Yokusoglu M, Gramatnikovski N, Ozal E, Tatar H. Tricuspid insufficiency does not increase early after permanent implantation of pacemaker leads. J Card Surg 2006;21:391-4.
12. Leibowitz DW, Rosenheck S, Pollak A, Geist M, Gilon D. Transvenous pacemaker leads do not worsen tricuspid regurgitation: a prospective echocardiographic study. Cardiology 2000;93:74-77
13. Huang TY, Baba N. Cardiac pathology of transvenous pacemakers. Am Heart Journal 1972;83:469-474
14. Chen TE, Wang CC, Chern MS, Chu JJ. Entrapment of permanent pacemaker lead as the cause of tricuspid regurgitation. Circ J 2007;71:1169-71.
15. WenBZong L, Liang M. Severe tricuspid valve regurgitation due to perforation by permanent pacemaker lead. J Card Surg 2011;26:555-6.
16. Mediratta A, Addetia K, Yamat M, Moss JD, Nayak HM, Burke MC, Weinert L, Maffessanti F, Jeevanandam V, MorBAvi V, Lang RM. 3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation. JACC Cardiovasc Imaging. 2014;7:337-47.
17. Alizadeh A, Sanati HR, HajiBKarimi M, Yazdi AH, Rad MA, Haghjoo M, Emkanjoo Z. Induction and aggravation of atrioventricular valve regurgitation in the course of chronic right ventricular apical pacing. Europace 2011;13:1587-90.
18. Vaturi M, Kusniec J, Shapira Y, Nevzorov R, Yedidya I, Weisenberg D, Monakier D, Strasberg B, Sagie A. Right ventricular pacing increases tricuspid regurgitation grade regardless of the mechanical interference to the valve by the electrode. Eur J Echocardiogr 2010;11:550-3.
19. Iskandar SB, Jackson A, Fahrig S, Mechleb BK, Garcia ID. Tricuspid valve malfunction and ventricular pacemaker lead: Case report and review of the literature. Echocardiography 2006;23:692-697
20. Nath J, Foster E, Heidenreich PA. Impact of Tricuspid regurgitation on longBterm survival. J Am Coll Cardiology 2004;43:405-409
21. Lin G, Nishimura RA, Connolly HM, Dearani J A, Sundt TM 3rd, Hayes DL. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverterBdefibrillator leads. J Am Coll Cardiol 2005; 45:1672-5.
22. AlBBawardy R, Krishnaswamy A, Bhargava M, Dunn J, Wazni O, Murat Tuzcu E, Stewart W, Kapadia SR. Tricuspid regurgitation in patients with pacemakers and implantable cardiac defibrillators: a comprehensive review. Clin Cardiol 2013;36:249-54.
23. AlBMohaissen MA, Chan KL. Prevalence and mechanism of tricuspid regurgitation following implantation of endocardial leads for pacemaker or cardioverterB defibrillator. J Am Soc Echocardiogr 2012;25:245-52.
24. Fazio S, Carlomagno G. The importance of tricuspid regurgitation and right ventricular overload in ICD/CRT recipients: beside the left, beyond the left. Pacing Clin Electrophysiol 2011;34:1181-4.
25. Höke U, Auger D, Thijssen J, Wolterbeek R, van der Velde ET, Holman ER, Schalij MJ, Bax JJ, Delgado V, Marsan NA Significant leadBinduced tricuspid regurgitation is associated with poor prognosis at longBterm followBup. Heart 2014;100:960-8.
26. Seo Y, Ishizu T, Nakajima H, Sekiguchi Y, Watanabe S, Aonuma K. Clinical utility of 3B dimensional echocardiography in the evaluation of tricuspid regurgitation caused by pacemaker leads. Circ J 2008;72:1465-70.
27. Nazmul MN, Cha YM, Lin G, Asirvatham SJ, Powell BD. Percutaneous pacemaker or implantable cardioverterBdefibrillator lead removal in an attempt to improve symptomatic tricuspid regurgitation. Europace 2013;15:409-13.
28. Pfannmueller B, Hirnle G, Seeburger J, Davierwala P, Schroeter T, Borger MA, Mohr FW. Tricuspid valve repair in the presence of a permanent ventricular pacemaker lead. Eur J Cardiothorac Surg 2011;39:657-61.
29. Zoghbi WA, EnriquezBSarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ. Recommendations for Evaluating of the Severity of Native Valvular Regurgitation with TwoB Dimensional and Doppler Echocardiography. J Am Soc of Echocardiography 2003;16: 777-802.
30. Rahko PS. Prevalence of regurgitant murmurs in patients with valvular regurgitation detected by Doppler echocardiography. Ann Internal medicine 1989;111:466-472.
31. Grossman G, Stein M, Kochs M, Hoher M, Koenig W, Hombach V, Giesler M. Comparison of the proximal flow convergence method and the jet area method for the assessment of the severity of tricuspid regurgitation. Eur Heart J 1998;19:652-9
32. Shapira Y, Porter A, Wurzel M, Vaturi, Sagie A. Evaluation of tricuspid regurgitation severity: echocardiographic and clinical correlation. J Am Soc Echocardiogr 1998; 11:652-659
33. Rivera JM, Vandervoort P, Mele D, Weyman A, Thomas JD. Value of proximal regurgitant jet size in tricuspid regurgitation. Am Heart J 1996;131: 742-747
34. Tribouilloy CM, EnriquiezBSarano M, Bailey KR, Tajik AJ, Seward JB. Quantification of tricuspid regurgitation by measuring the width of the vena contracta with Doppler color flow imaging: a clinical study. J Am Cardiol 2000;36:472-8
35. Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M, Rashtian M, Kremers M, Crozier I, Lee KL, Smith W, Burke MC. Safety and efficacy of a totally subcutaneous implantableB cardioverter defibrillator. Circulation 2013;128:944-53.
36. Auricchio A, Delnoy PP, Regoli F, Seifert M, Markou T, Butter C; collaborative study group. FirstBinBman implantation of leadless ultrasoundBbased cardiac stimulation pacing system: novel endocardial left ventricular resynchronization therapy in heart failure patients. Europace 2013;15:1191-7.